Jakavi 5mg / ml Oral solution

Licence status
Authorised: 13/01/2025
Active substances
Ruxolitinib phosphate
Dosage Form
Oral solution
Licence number
EU/1/12/773/017
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
L01EJ01 ruxolitinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
13/01/2025